OnKure Therapeutics, Inc.
OKUR
$3.99
$0.092.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.25% | -12.25% | 8.14% | 4.49% | 3.36% |
| Total Depreciation and Amortization | -7.39% | 0.50% | -0.98% | -3.77% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.60% | -8.04% | 2.02% | 1.89% | 5.94% |
| Change in Net Operating Assets | 333.64% | 38.09% | 18.01% | -49.90% | 3.18% |
| Cash from Operations | 19.97% | -12.39% | 11.70% | 1.79% | 5.22% |
| Capital Expenditure | 40.00% | 44.44% | -50.00% | 53.85% | 27.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -197,300.00% | 44.44% | -50.00% | 53.85% | 27.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.12% | 60,732.92% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -103.68% | 60,732.92% | -- | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.24% | 1,279.47% | 13.51% | 1.84% | 5.77% |